We use cookies to see how investors use El Fondo and make its tools, data and markets better for you. You can accept or reject; essential cookies always stay on. Privacy Policy
Trades about 34% below its sector, cheaper than its peers on earnings.
Vital KSK Holdings, Inc. is a Japanese entity primarily involved in the wholesale distribution of pharmaceutical products. Its diverse wholesale operations also cover veterinary medications, agricultural chemicals and supplies, and various types of medical and nursing care equipment. Beyond its core distribution activities, the company manages a range of services including operating pharmacies, providing nursing care, transportation, insurance agency services, real estate management, and parking facilities. It also runs a mail-order business focused on health-related products and offers pharmacy dispensing services. Furthermore, Vital KSK Holdings provides medical management consulting and manufactures over-the-counter (OTC) drugs. The company was established in 2009 and maintains its headquarters in Tokyo, Japan.
Loading the full price history…
Run your own numbersPast performance is not a forecast.
Save 3151.T and get told when something moves.
Get updates
A clear, direct weekly summary.
Learn the fundamentals behind this asset.
A stock is a fraction of ownership in a real company. Buy one share and you own a piece (usually a tiny piece) of every desk, factory, contract and brand the company runs. The price moves because the market keeps revising what that whole pie is worth.
The price-to-earnings ratio is how much investors are paying for one dollar of a company's profit. A multiple, never an absolute. Always compared to something: a sector, a region, the company's own past.
Dividend yield is the annual income a stock or ETF pays out, expressed as a percentage of what you paid for it. It is the visible part of total return: the cash that lands in your account every quarter, and the lever most retail investors actually feel.
Market cap is shares times price. A simple formula that produces wildly unequal numbers: a single US tech name can be worth more than every company on a LATAM exchange combined.
